Align Technology, Inc. (NASDAQ:ALGN – Get Free Report)’s share price gapped up before the market opened on Thursday after Morgan Stanley raised their price target on the stock from $344.00 to $360.00. The stock had previously closed at $313.78, but opened at $325.00. Morgan Stanley currently has an overweight rating on the stock. Align Technology shares last traded at $301.46, with a volume of 543,779 shares traded.
Several other research firms have also weighed in on ALGN. Piper Sandler reissued an “overweight” rating and set a $375.00 price target (up from $355.00) on shares of Align Technology in a research report on Thursday. SVB Leerink initiated coverage on Align Technology in a research report on Monday, February 26th. They set a “market perform” rating and a $310.00 price target on the stock. The Goldman Sachs Group upped their price target on Align Technology from $197.00 to $225.00 and gave the company a “sell” rating in a research report on Friday, February 2nd. UBS Group upped their price target on Align Technology from $280.00 to $320.00 and gave the company a “neutral” rating in a research report on Monday, April 15th. Finally, Robert W. Baird upped their price target on Align Technology from $333.00 to $370.00 and gave the company an “outperform” rating in a research report on Thursday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $341.36.
Get Our Latest Stock Analysis on Align Technology
Insiders Place Their Bets
Institutional Trading of Align Technology
Several large investors have recently made changes to their positions in ALGN. DAVENPORT & Co LLC boosted its stake in Align Technology by 3.1% during the 3rd quarter. DAVENPORT & Co LLC now owns 2,172 shares of the medical equipment provider’s stock valued at $663,000 after purchasing an additional 66 shares during the period. Czech National Bank boosted its stake in Align Technology by 47.7% during the 3rd quarter. Czech National Bank now owns 12,441 shares of the medical equipment provider’s stock valued at $3,798,000 after purchasing an additional 4,016 shares during the period. Asset Management One Co. Ltd. boosted its stake in Align Technology by 1.3% during the 3rd quarter. Asset Management One Co. Ltd. now owns 30,319 shares of the medical equipment provider’s stock valued at $9,257,000 after purchasing an additional 387 shares during the period. Handelsbanken Fonder AB boosted its stake in Align Technology by 3.0% during the 3rd quarter. Handelsbanken Fonder AB now owns 32,348 shares of the medical equipment provider’s stock valued at $9,876,000 after purchasing an additional 936 shares during the period. Finally, Slow Capital Inc. boosted its stake in Align Technology by 0.8% during the 3rd quarter. Slow Capital Inc. now owns 9,281 shares of the medical equipment provider’s stock valued at $2,834,000 after purchasing an additional 70 shares during the period. Institutional investors own 88.43% of the company’s stock.
Align Technology Stock Performance
The firm has a 50 day moving average of $313.38 and a two-hundred day moving average of $270.98. The stock has a market cap of $23.25 billion, a P/E ratio of 50.91, a P/E/G ratio of 5.62 and a beta of 1.65.
Align Technology (NASDAQ:ALGN – Get Free Report) last announced its earnings results on Wednesday, January 31st. The medical equipment provider reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.13. The firm had revenue of $956.73 million during the quarter, compared to the consensus estimate of $928.57 million. Align Technology had a return on equity of 14.22% and a net margin of 11.80%. On average, sell-side analysts anticipate that Align Technology, Inc. will post 7.69 EPS for the current fiscal year.
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Further Reading
- Five stocks we like better than Align Technology
- The “How” and “Why” of Investing in 5G Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Read Stock Charts for Beginners
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Evaluate a Stock Before BuyingÂ
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.